Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Crispin

Showing results (121-130 of 230) with videos related to

Pageof 23
Sort By:
The Journal of Biological Chemistry|March 27, 2014
Fragments of bacterial endoglycosidase s and immunoglobulin g reveal subdomains of each that contribute to deglycosylationEmma V Dixon, Jolyon K Claridge, David J Harvey, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 10, 2025
mRNA prime-boost vaccination promotes clonal continuity in germinal center reactions and broadens SARS-CoV-2 variant coverageMatias Ciancaglini, Jonas Fixemer, Cemre Seven, et al.
Science (New York, N.Y.)|October 20, 2022
Structure of the hepatitis C virus E1E2 glycoprotein complexAlba Torrents de la Peña, Kwinten Sliepen, Lisa Eshun-Wilson, et al.
Plos Pathogens|October 30, 2023
Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralizationRajesh P Ringe, Philippe Colin, Gabriel Ozorowski, et al.
Advances in Experimental Medicine and Biology|January 13, 2004
Crystal structure of an intact human IgG: antibody asymmetry, flexibility, and a guide for HIV-1 vaccine designErica Ollmann Saphire, Robyn L Stanfield, M D Max Crispin, et al.
Science Translational Medicine|March 18, 2021
Effector function does not contribute to protection from virus challenge by a highly potent HIV broadly neutralizing antibody in nonhuman primatesLars Hangartner, David Beauparlant, Eva Rakasz, et al.
Cell|September 27, 2020
Molecular Architecture of the SARS-CoV-2 VirusHangping Yao, Yutong Song, Yong Chen, et al.
Vaccines|February 26, 2025
The Design and Immunogenicity of an HIV-1 Clade C Pediatric Envelope Glycoprotein Stabilized by Multiple PlatformsSanjeev Kumar, Iván Del Moral-Sánchez, Swarandeep Singh, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Rational design of next-generation filovirus vaccines with glycoprotein stabilization, nanoparticle display, and glycan modificationYi-Zong Lee, Yi-Nan Zhang, Maddy L Newby, et al.
Nature Communications|December 12, 2025
Rational design of next-generation filovirus vaccines combining glycoprotein stabilization and nanoparticle display with glycan modificationYi-Zong Lee, Yi-Nan Zhang, Maddy L Newby, et al.
Pageof 23

Showing results (121-130 of 230) with videos related to

Sort By:
Pageof 23
The Journal of Biological Chemistry|March 27, 2014
Fragments of bacterial endoglycosidase s and immunoglobulin g reveal subdomains of each that contribute to deglycosylationEmma V Dixon, Jolyon K Claridge, David J Harvey, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 10, 2025
mRNA prime-boost vaccination promotes clonal continuity in germinal center reactions and broadens SARS-CoV-2 variant coverageMatias Ciancaglini, Jonas Fixemer, Cemre Seven, et al.
Science (New York, N.Y.)|October 20, 2022
Structure of the hepatitis C virus E1E2 glycoprotein complexAlba Torrents de la Peña, Kwinten Sliepen, Lisa Eshun-Wilson, et al.
Plos Pathogens|October 30, 2023
Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralizationRajesh P Ringe, Philippe Colin, Gabriel Ozorowski, et al.
Advances in Experimental Medicine and Biology|January 13, 2004
Crystal structure of an intact human IgG: antibody asymmetry, flexibility, and a guide for HIV-1 vaccine designErica Ollmann Saphire, Robyn L Stanfield, M D Max Crispin, et al.
Science Translational Medicine|March 18, 2021
Effector function does not contribute to protection from virus challenge by a highly potent HIV broadly neutralizing antibody in nonhuman primatesLars Hangartner, David Beauparlant, Eva Rakasz, et al.
Cell|September 27, 2020
Molecular Architecture of the SARS-CoV-2 VirusHangping Yao, Yutong Song, Yong Chen, et al.
Vaccines|February 26, 2025
The Design and Immunogenicity of an HIV-1 Clade C Pediatric Envelope Glycoprotein Stabilized by Multiple PlatformsSanjeev Kumar, Iván Del Moral-Sánchez, Swarandeep Singh, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Rational design of next-generation filovirus vaccines with glycoprotein stabilization, nanoparticle display, and glycan modificationYi-Zong Lee, Yi-Nan Zhang, Maddy L Newby, et al.
Nature Communications|December 12, 2025
Rational design of next-generation filovirus vaccines combining glycoprotein stabilization and nanoparticle display with glycan modificationYi-Zong Lee, Yi-Nan Zhang, Maddy L Newby, et al.
Pageof 23